This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Corrigendum to Gamabufotalin suppressed osteosarcoma stem cells through the TGF-β/periostin/PI3K/AKT pathway [Chem. Biol. Interact. 2020 Nov 1;331:109275]. (25th January 2022)
Record Type:
Journal Article
Title:
Corrigendum to Gamabufotalin suppressed osteosarcoma stem cells through the TGF-β/periostin/PI3K/AKT pathway [Chem. Biol. Interact. 2020 Nov 1;331:109275]. (25th January 2022)
Main Title:
Corrigendum to Gamabufotalin suppressed osteosarcoma stem cells through the TGF-β/periostin/PI3K/AKT pathway [Chem. Biol. Interact. 2020 Nov 1;331:109275]